FDA Rebukes Pharma Lab For Operating Microbrewery Within Drug Testing Area


By Morgan Haefner

The Food and Drug Administration issued a warning letter to Pharmaceutical Laboratories and Consultants referencing several violations at the Addison, Ill.-based lab, including the presence of a microbrewery in its drug testing area.

The FDA's inspection revealed the lab's president and owner, James Stephen, operated the microbrewery where his pharmaceutical firm tested over-the-counter drugs and products. From Sept. 18 to Oct. 10, inspectors found microbiology lab media stored in the same area brewery materials were stored, which the FDA said posed "unacceptable risks" like contamination.

In its warning letter, the FDA noted other significant violations of standard manufacturing practices pertaining to the lab's scientific methods, facilities, processes, packaging and storing.

The FDA found similar deficiencies at Pharmaceutical Laboratories and Consultants dating back as far as 2007. The agency said if the pharmaceutical lab fails to correct the violations, legal actions may follow without further notice.


Articles in this issue:

Journal of Medicine Sign Up

Get the Journal of Medicine delivered to your inbox.

No membership required*
Thank you for subscribing.


    • Masthead

    • Editor-in Chief:
    • Theodore Massey
    • Editor:
    • Robert Sokonow
    • Editorial Staff:
    • Musaba Dekau
      Lin Takahashi
      Thomas Levine
      Cynthia Casteneda Avina
      Ronald Harvinger
      Lisa Andonis

Leave a Comment

Please keep in mind that all comments are moderated. Please do not use a spam keyword or a domain as your name, or else it will be deleted. Let's have a personal and meaningful conversation instead. Thanks for your comments!

Image Captcha